![Caroline Germa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Caroline Germa currently works at Transcenta Holding Ltd., as Chief Medical Officer & Executive Vice President from 2022.
Dr. Germa also formerly worked at AstraZeneca PLC, as Vice President & Head-Early Development Clinical and Ikena Oncology, Inc., as Chief Medical Officer from 2024 to 2025.
Dr. Germa received her undergraduate degree from Universite Paris Cite and undergraduate degree and doctorate degree from Université De Lille.
| Sociétés | Poste | Début |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Directeur Technique/Scientifique/R&D | 08/08/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| IMAGENEBIO, INC. | Directeur Technique/Scientifique/R&D | 03/02/2025 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 07/08/2022 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ikena Oncology, Inc.
 Ikena Oncology, Inc. BiotechnologyHealth Technology Develops metabolic enzymes based immunotherapy for oncology applications | Health Technology |
Transcenta Holding Ltd.
 Transcenta Holding Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that manufactures and wholesales pharmaceutical products | Health Technology |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université De Lille
 Université De Lille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
